SAR439859
oral sel. estrogen receptor degrader (SERD) 400 mg QD, in Ph. II for ER+/HER2- BC from MTS of ER binders, opt. for degrd./antag. Mol. Cancer Ther., Dec. 11, 2020 Sanofi, Vitry-sur-Seine, FR / Cambridge MA
Molecules of the Month - December 2020
Molecules of the Month
- OI338
- PF07059013
- AZD0364
- PF-06843195
- TP0586352
- AZD4573
- "compound 42"
- "compound 12"
- BMS-986202
- pamiparib
- linrodostat
- SAR439859
- ACT-1004-1239
- "compound 1"